Insulin aspart, recombinant Subcutaneous and Remeron Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Remeron Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mirtazapine
Brand name: Remeron, Remeron SolTab
Synonyms: Mirtazapine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Remicade
- Insulin aspart, recombinant Subcutaneous-Remifentanil
- Insulin aspart, recombinant Subcutaneous-Remifentanil Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Remifentanil Injection
- Insulin aspart, recombinant Subcutaneous-Remifentanil Intravenous
- Insulin aspart, recombinant Subcutaneous-Reminyl
- Remeron Tablets-Insulin degludec
- Remeron Tablets-Insulin Degludec (U-100) Prefilled Pens
- Remeron Tablets-Insulin Degludec (U-100) Vials
- Remeron Tablets-Insulin Degludec (U-200) Prefilled Pens
- Remeron Tablets-Insulin degludec and liraglutide
- Remeron Tablets-Insulin degludec and liraglutide Subcutaneous